Optimal surgery for advanced gastric cancer

References

• Macintyre IM, Akoh JA. Improving survival in gastric cancer: review of operative mortality in English language publications from 1970. Br. J. Surg.78, 771–776 (1991).
   Google Scholar
• Akoh JA, Macintyre IM. Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br. J. Surg.79(4), 293–299 (1992).
   PubMed Web of Science ®Google Scholar
• Wanebo H, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann. Surg.218, 583–592 (1993).
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Maruyama K, Sasako M et al. Treatment results of gastric cancer patients: Japanese experience. In: Gastric Cancer. Nishi M, Ichakawa H, Nakajima T et al (Eds). Springer-Verlag, Tokyo, Japan 319–330 (1993).
   Google Scholar
• Soga J, Kobayashi K, Saito J, Fujimaki M, Muto T. The role of lymphadenectomy in curative surgery for gastric cancer. World J. Surg.3(6), 701–708 (1979).
   Google Scholar
• Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N. Engl. J. Med.340, 908–914 (1999).
   PubMed Web of Science ®Google Scholar
• Bonenkamp JJ, van de Velde CJ, Kampschoer GH et al. Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients. World J. Surg.17(3), 410–414 (1993).
   PubMed Web of Science ®Google Scholar
• Cuschieri A. Recent advances in gastrointestinal malignancy. Ann. Chir. Gynaecol.78(3), 228–237 (1989).
   PubMedGoogle Scholar
• Siewert JR, Bottcher K, Roder JD et al. Prognostic relevance of systemic lymph node dissection in gastric carcinoma. Br. J. Surg.80, 1015–1018 (1993).
   PubMed Web of Science ®Google Scholar
• Sue-Ling HM, Johnston D, Martin IG et al. Gastric cancer: a curable disease in Britain [see comments]. BMJ307(6904), 591–596 (1993).
   PubMedGoogle Scholar
• Arak A, Kull K. Factors influencing survival of patients after radical surgery for gastric cancer. A regional study of 406 patients over a 10-year period. Acta Oncol.33(8), 913–920 (1994).
   PubMed Web of Science ®Google Scholar
• Wanebo HJ, Kennedy BJ, Winchester DP et al. Gastric carcinoma: does lymph node dissection alter survival? J. Am. Coll. Surg.183, 616 (1996).
   PubMed Web of Science ®Google Scholar
• Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br. J. Surg.75, 110–112 (1988).
   PubMed Web of Science ®Google Scholar
• Robertson CS, Chung SC, Woods SD et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann. Surg.220, 176–182 (1994).
   PubMed Web of Science ®Google Scholar
• Hartgrink HH, van de Velde CJ, Putter H et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J. Clin. Oncol.22(11), 2069–2077 (2004).
   PubMed Web of Science ®Google Scholar
• Cuschieri A, Weeden S, Fielding J et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative group. Br. J. Cancer79(9–10), 1522–1530 (1999).
   PubMed Web of Science ®Google Scholar
• McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst. Rev.CD001964 (2004).
   Google Scholar
• Degiuli M, Sasako M, Calgaro M et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur. J. Surg. Oncol.30(3), 303–308 (2004).
   PubMed Web of Science ®Google Scholar
• Wu CW, Hsiung CA, Lo SS et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol.7, 309–315 (2006).
   PubMed Web of Science ®Google Scholar
• Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Szczepanik A. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer. An interim safety analysis of a multicenter, randomized, clinical trial. Am. J. Surg.193(1), 10–15 (2007).
   Google Scholar
• Yonemura Y, Wu C-C, Fukushima N et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int. J. Clin. Oncol.13, 132–137 (2008).
   Google Scholar
• Sasako M, Sano T, Yamamoto S et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N. Engl. J. Med.359(5), 453–462 (2008).
   PubMed Web of Science ®Google Scholar
• Viste A, Ha’ugstvedt T, Eide GE, Sreide O. Postoperative complications and mortality after surgery for gastric cancer. Ann. Surg.207, 7–13 (1988).
   PubMed Web of Science ®Google Scholar
• Bottcher K, Siewert JR, Roder JD, Busch R, Hermanek P, Meyer HJ. Risk of surgical therapy of stomach cancer in Germany. Results of the German 1992 Stomach Cancer Study. German Stomach Cancer Study Group (‘92). Chirurg65(4), 298–306 (1994).
   Google Scholar
• Gennari L, Bozzetti F, Bonfanti G et al. Subtotal versus total gastrectomy for cancer of the lower two- thirds of the stomach: a new approach to an old problem. Br. J. Surg.73, 534–538 (1986).
   PubMed Web of Science ®Google Scholar
• Cuschieri A, Fayers P, Fielding J et al. Postoperative morbidity amd mortality after D1 and D2 resection for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet347, 995–999 (1996).
   PubMed Web of Science ®Google Scholar
• Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br. J. Surg.84(11), 1567–1571 (1997).
   Google Scholar
• Songun I, Bonenkamp JJ, Hermans J, van Krieken JH, van de Velde CJ. Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur. J. Cancer32A(3), 433–437 (1996).
   Google Scholar
• Kim SH, Karpeh MS, Klimstra DS, Leung D, Brennan MF. Effect of microscopic resection line disease on gastric cancer survival. J. Gastrointest. Surg.3, 24–33 (1999).
   Google Scholar
• Bozzetti F, Marubini E, Bonfanti G et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann. Surg.230, 170–178 (1999).
   PubMed Web of Science ®Google Scholar
• Kim JH, Park SS, Kim J et al. Surgical outcomes for gastric cancer in the upper third of the stomach. World J. Surg.30, 1870–1876 (2006).
   PubMed Web of Science ®Google Scholar
• Kodera Y, Yamamura Y, Shimizu Y et al. Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma. World J. Surg.21(6), 622–627 (1997).
   Google Scholar
• Kitamura K, Nishida S, Ichikawa D et al. No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer. Br. J. Surg.86(1), 119–122 (1999).
   Google Scholar
• Wu CW, Chang IS, Lo SS et al. Complications following D3 gastrectomy. post hoc analysis of a randomized trial. World J. Surg.30(1), 12–16 (2006).
   Google Scholar
• Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br. J. Surg.92(9), 1103–1109 (2005).
   Google Scholar
• Csendes A, Burdiles P, Rojas J et al. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery131, 401–407 (2002).
   PubMed Web of Science ®Google Scholar
• Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br. J. Surg.93, 559–563 (2006).
   Google Scholar
• Wang JY, Huang TJ, Chen FM et al. A comparative study of pancreatectomy and pancreas-preserving gastrectomy in advanced gastric carcinomas. Hepatogastroenterology51, 1229–1232 (2004).
   PubMedGoogle Scholar
• Kunisaki C, Shimada H, Nomura M et al. Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res.25(2B), 1369–1375 (2005).
   PubMed Web of Science ®Google Scholar
• Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J. Clin. Oncol.23, 7114–7124 (2005).
   PubMed Web of Science ®Google Scholar
• Marchet A, Mocellin S, Ambrosi A et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large multicenter trial. Eur. J. Surg. Oncol.34(2), 159–165 (2008).
   PubMed Web of Science ®Google Scholar
• Kampschoer GH, Maruyama K, van de Velde CJH, Sasako M, Kinoshita T, Okabayashi K. Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br. J. Surg.76, 905–908 (1989).
   PubMed Web of Science ®Google Scholar
• Peeters KC, Hundahl SA, Kranenbarg EK et al. Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1–D2 trial. World J. Surg.29, 1576–1584 (2005).
   Google Scholar
• Hundahl SA, Peeters KC, Kranenbarg EK et al. Improved regional control and survival with ‘low Maruyama Index’ surgery in gastric cancer: autopsy findings from the Dutch D1–D2 Trial. Gastric Cancer10, 84–86 (2007).
   Google Scholar
• Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann. Surg. Oncol.9, 278–286 (2002).
   PubMed Web of Science ®Google Scholar
• Siewert JR, Kelsen D, Maruyama K et al.Gastric Cancer Diagnosis and Treatment – An Interactive Training Program (1st Edition). Springer Electronic Media, Heidelberg, Germany (2000).
   Google Scholar
• Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J. Clin. Oncol.21(19), 3647–3650 (2003).
   PubMed Web of Science ®Google Scholar
• Peeters KC, Kattan MW, Hartgrink HH et al. Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer103(4), 702–707 (2005).
   Google Scholar
• Novotny AR, Schuhmacher C, Busch R et al. Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann. Surg.243(1), 74–81 (2006).
   Google Scholar
• Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann. Intern. Med.137, 511–520 (2002).
   PubMed Web of Science ®Google Scholar
• Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann. Surg.245, 777–783 (2007).
   PubMed Web of Science ®Google Scholar
• Damhuis RA, Meurs CJ, Dijkhuis CM, Stassen LP, Wiggers T. Hospital volume and post-operative mortality after resection for gastric cancer. Eur. J. Surg. Oncol.28, 401–405 (2002).
   PubMedGoogle Scholar
• Thompson AM, Rapson T, Gilbert FJ, Park KG. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br. J. Surg.94, 578–584 (2007).
   Google Scholar
• Wenner J, Zilling T, Bladstrom A, Alvegard TA. The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia. Anticancer Res.25, 419–424 (2005).
   Google Scholar
• Xirasagar S, Lien YC, Lin HC, Lee HC, Liu TC, Tsai J. Procedure volume of gastric cancer resections versus 5-year survival. Eur. J. Surg. Oncol.34, 23–29 (2008).
   Google Scholar
• Meyer HJ. The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. Eur. J. Surg. Oncol.31, 595–604 (2005).
   PubMedGoogle Scholar
• Bachmann MO, Alderson D, Edwards D et al. Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers. Br. J. Surg.89, 914–922 (2002).
   PubMedGoogle Scholar
• Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N. Engl. J. Med.349, 2117–2127 (2003).
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Feinglass JM et al. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J. Clin. Oncol.26, 4626–4633 (2008).
   Google Scholar
• McCulloch P, Niita ME, Kazi H, Gama-Rodrigues JJ. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br. J. Surg.92(1), 5–13 (2005).
   Google Scholar
• McCulloch P. D1 versus D2 dissection for gastric cancer (letter). Lancet158, 413–418 (1995).
   Google Scholar
• Parikh D, Johnson M, Chagla L, Lowe D, McCulloch P. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br. J. Surg.83(11), 1595–1599 (1996).
   Google Scholar
• Krijnen P, den Dulk M, Meershoek-Klein Kranenbarg E, Jansen-Landheer ML, van de Velde CJ. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control. Eur. J. Surg. Oncol.35(7), 715–720 (2009).
   Google Scholar
• Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann. Surg.210, 596–602 (1989).
   PubMed Web of Science ®Google Scholar
• Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int. J. Radiat. Oncol. Biol. Phys.8, 1–11 (1992).
   Google Scholar
• Allum WH, Hallissey MT, Ward LC, Hockey MS. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group. Br. J. Cancer60, 739–744 (1989).
   PubMed Web of Science ®Google Scholar
• Cunningham D, Allum WH, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med.355(1), 11–20 (2006).
   PubMed Web of Science ®Google Scholar
• MacDonald J, Smalley S, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N. Engl. J. Med.345, 725–730 (2001).
   PubMed Web of Science ®Google Scholar
• Sakuramoto S, Sasako M, Yamaguchi T et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N. Engl. J. Med.357(18), 1810–1820 (2007).
   PubMed Web of Science ®Google Scholar
• Song J, Oh SJ, Kang WH, Hyung WJ, Choi SH, Noh SH. Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures. Ann. Surg.249(6), 927–932 (2009).
   PubMed Web of Science ®Google Scholar
• Japanese Research Society of Gastric Cancer. Japanese Classification of Gastric Carcinoma. First English Edition. Kanehara and Co., Ltd, Tokyo, Japan (1995).
   Google Scholar